Please use this identifier to cite or link to this item:
|Title:||Proteomics and metabolomics analysis of cellular responses to β-blocker carvedilol||Authors:||Wang, Mingxuan||Keywords:||DRNTU::Engineering::Chemical engineering::Biochemical engineering||Issue Date:||2012||Source:||Wang, M. X. (2012). Proteomics and metabolomics analysis of cellular responses to β-blocker carvedilol. Doctoral thesis, Nanyang Technological University, Singapore.||Abstract:||Currently, drug discovery and development is extremely expensive and time consuming, which results in low rates of new drugs reaching the market. One solution to alleviating this problem is to gain a better understanding of existing drug-cell interactions that will provide valuable insights into drug redeployment and new drug design. Protein and metabolite concentrations represent sensitive markers of cellular responses to drug treatment. Consequently, developing robust cell line-based proteomics and metabolomics platforms will greatly facilitate understanding of drug-cell interactions.||URI:||https://hdl.handle.net/10356/50476||DOI:||10.32657/10356/50476||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||SCBE Theses|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.